- 1 analyst, 1 voteThe latest Buy, Hold or Sell from every analyst covering a stock.
- Price targetsTheir average target, the range, and the upside against today's price.
- Radar picks →The stocks our model scores highest in each index.
Russell 2000 analyst ratings
1,952 stocks · 1,852 covered · 15,462 votes ·
Ranking as of analyst data of 7 Nov 2026
| #Stock | Price · day | Buy / Hold / Sell | Avg target · range (USD) | Upside | Latest target report | Next earnings | Data status | Analysts | Report dates |
|---|---|---|---|---|---|---|---|---|---|
| 11.59+10.07% | Buy 11 · Hold 1 · Sell 0 · 92% Buy | 25.2920.00–35.00 | +118.2%+13.70 USD | 21 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:19 ET | 1313 firms | avg 31 Jul10 Jun 2026 – 21 Sep 2026 | |
202BHVNBIOHAVEN | 14.48+4.17% | Buy 11 · Hold 5 · Sell 1 · 65% Buy | 21.4010.00–48.00 | +47.8%+6.92 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:56 ET | 2121 firms | avg 20 Jul18 Nov 2025 – 3 Nov 2026 |
| 4.59−10.00% | Buy 11 · Hold 1 · Sell 1 · 85% Buy | 10.445.30–16.00 | +127.5%+5.85 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:02 ET | 1614 firms | avg 10 Aug26 Feb 2026 – 19 Oct 2026 | |
| 10.52−0.75% | Buy 11 · Hold 4 · Sell 1 · 69% Buy | 13.528.75–17.50 | +28.5%+3.00 USD | 30 OctPartial coverage · checked 6 Nov | 29 JanEstimated | Partial coverage6 Nov 02:42 ET | 1818 firms | avg 21 Oct28 Sep 2026 – 30 Oct 2026 | |
| 12.79+4.41% | Buy 11 · Hold 0 · Sell 1 · 92% Buy | 21.8617.00–26.00 | +70.9%+9.07 USD | 21 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 07:07 ET | 1313 firms | avg 8 Sep25 Jun 2026 – 21 Oct 2026 | |
| 51.35+5.96% | Buy 11 · Hold 1 · Sell 1 · 85% Buy | 87.0019.00–150.00 | +69.4%+35.65 USD | 13 OctPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 02:55 ET | 1313 firms | avg 14 Jul13 Mar 2026 – 13 Oct 2026 | |
| 41.83+12.39% | Buy 11 · Hold 0 · Sell 1 · 92% Buy | 87.0060.00–100.00 | +108.0%+45.17 USD | 9 OctPartial coverage · checked 6 Nov | 5 JanEstimated | Partial coverage6 Nov 05:49 ET | 1412 firms | avg 2 Sep15 Apr 2026 – 9 Oct 2026 | |
| 40.96+1.69% | Buy 11 · Hold 1 · Sell 1 · 85% Buy | 55.2550.00–65.00 | +34.9%+14.29 USD | 5 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:46 ET | 1515 firms | avg 21 Aug8 May 2026 – 5 Nov 2026 | |
| 3.90+8.03% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 10.457.00–16.00 | +168.1%+6.55 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:14 ET | 1414 firms | avg 15 Jul6 Jan 2026 – 28 Oct 2026 | |
| 15.82+6.53% | Buy 10 · Hold 0 · Sell 0 · 100% Buy | 35.8833.00–40.00 | +126.8%+20.06 USD | 2 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 06:11 ET | 1111 firms | avg 7 Jul3 Feb 2026 – 2 Oct 2026 | |
| 7.34−2.91% | Buy 10 · Hold 5 · Sell 0 · 67% Buy | 15.238.00–28.00 | +107.5%+7.89 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:55 ET | 1817 firms | avg 20 Sep6 Jul 2026 – 30 Oct 2026 | |
| 2.08+5.58% | Buy 10 · Hold 3 · Sell 0 · 77% Buy | 13.952.50–28.00 | +570.7%+11.87 USD | 23 SepPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 06:13 ET | 1413 firms | avg 8 Jun27 Jan 2026 – 23 Sep 2026 | |
| 16.70+3.73% | Buy 10 · Hold 4 · Sell 0 · 71% Buy | 14.5910.00–18.00 | −12.6%−2.11 USD | 20 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:04 ET | 1514 firms | avg 15 Aug1 Jun 2026 – 20 Oct 2026 | |
| 25.16+15.04% | Buy 10 · Hold 2 · Sell 0 · 83% Buy | 38.1126.00–60.00 | +51.5%+12.95 USD | 19 OctPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 06:10 ET | 1313 firms | avg 8 Jul2 Apr 2026 – 19 Oct 2026 | |
| 10.20+10.15% | Buy 10 · Hold 2 · Sell 0 · 83% Buy | 28.4513.00–45.00 | +179.0%+18.25 USD | 22 OctPartial coverage · checked 6 Nov | 11 NovConfirmed | Partial coverage6 Nov 07:00 ET | 1414 firms | avg 24 Aug12 May 2026 – 22 Oct 2026 | |
| 27.12+12.77% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 31.4024.00–37.00 | +15.8%+4.28 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:49 ET | 1212 firms | avg 21 Jun17 Dec 2025 – 21 Oct 2026 | |
| 9.54+10.42% | Buy 10 · Hold 2 · Sell 0 · 83% Buy | 22.8614.00–32.00 | +139.6%+13.32 USD | 23 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 07:03 ET | 1313 firms | avg 12 Jul25 Feb 2026 – 23 Oct 2026 | |
| 3.10+5.08% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 14.567.00–30.00 | +369.5%+11.46 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:58 ET | 1212 firms | avg 21 Jul23 Feb 2026 – 28 Oct 2026 | |
| 38.90−2.85% | Buy 10 · Hold 6 · Sell 0 · 63% Buy | 39.6030.00–48.00 | +1.8%+0.70 USD | 23 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:44 ET | 1817 firms | avg 23 Aug2 Jul 2026 – 23 Oct 2026 | |
| 62.45−1.85% | Buy 10 · Hold 4 · Sell 0 · 71% Buy | 75.5554.00–90.00 | +21.0%+13.10 USD | 23 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:49 ET | 1515 firms | avg 21 Jul17 Nov 2025 – 23 Oct 2026 | |
| 42.22+0.17% | Buy 10 · Hold 0 · Sell 0 · 100% Buy | 42.7140.00–47.00 | +1.2%+0.49 USD | 20 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:42 ET | 1111 firms | avg 21 Aug10 May 2026 – 20 Oct 2026 | |
| 3.07+7.34% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 35.6028.00–48.00 | +1,059.6%+32.53 USD | 14 SepPartial coverage · checked 6 Nov | 16 NovEstimated | Partial coverage6 Nov 03:45 ET | 1312 firms | avg 9 Jul9 Mar 2026 – 14 Sep 2026 | |
| 12.70−0.78% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 21.6715.00–29.00 | +70.6%+8.97 USD | 16 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:09 ET | 1212 firms | avg 7 Jul25 Nov 2025 – 16 Oct 2026 | |
| 23.70+8.42% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 46.8940.00–60.00 | +97.8%+23.19 USD | 29 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:07 ET | 1212 firms | avg 22 Jun17 Feb 2026 – 29 Sep 2026 | |
| 23.00+11.11% | Buy 10 · Hold 2 · Sell 0 · 83% Buy | 146.33107.00–220.00 | +536.2%+123.33 USD | 3 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:31 ET | 1212 firms | avg 4 Oct19 Aug 2026 – 3 Nov 2026 | |
| 2.57+0.78% | Buy 10 · Hold 3 · Sell 0 · 77% Buy | 6.143.50–15.00 | +138.8%+3.57 USD | 8 OctPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 06:59 ET | 1414 firms | avg 26 Jun10 Mar 2026 – 8 Oct 2026 | |
| 10.57+3.12% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 27.6325.00–37.00 | +161.4%+17.06 USD | 5 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:07 ET | 1414 firms | avg 26 Aug27 Jul 2026 – 5 Oct 2026 | |
| 52.40+0.87% | Buy 10 · Hold 3 · Sell 0 · 77% Buy | 48.1139.00–64.00 | −8.2%−4.29 USD | 20 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 04:44 ET | 1514 firms | avg 24 Aug30 Jun 2026 – 20 Oct 2026 | |
| 30.53+7.54% | Buy 10 · Hold 6 · Sell 0 · 63% Buy | 45.4630.00–62.00 | +48.9%+14.93 USD | 24 SepPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 04:47 ET | 1717 firms | avg 8 Jul2 Apr 2026 – 24 Sep 2026 | |
| 98.02+3.76% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 106.6756.00–140.00 | +8.8%+8.65 USD | 16 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:39 ET | 1212 firms | avg 19 Jul21 Jan 2026 – 16 Oct 2026 | |
| 1.87+13.33% | Buy 10 · Hold 2 · Sell 0 · 83% Buy | 6.154.00–10.00 | +228.9%+4.28 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:53 ET | 1515 firms | avg 4 Aug11 May 2026 – 29 Oct 2026 | |
| 11.96+5.37% | Buy 10 · Hold 5 · Sell 0 · 67% Buy | 26.9219.00–36.00 | +125.1%+14.96 USD | 26 OctPartial coverage · checked 6 Nov | 27 JanEstimated | Partial coverage6 Nov 02:47 ET | 1615 firms | avg 9 Aug10 Dec 2025 – 26 Oct 2026 | |
| 2.37+3.49% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 7.805.00–15.00 | +229.1%+5.43 USD | 17 SepPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 08:13 ET | 1311 firms | avg 9 Aug7 May 2026 – 17 Sep 2026 | |
| 306.20+2.41% | Buy 10 · Hold 0 · Sell 0 · 100% Buy | 353.80326.00–397.00 | +15.5%+47.60 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:08 ET | 1111 firms | avg 22 Aug8 Jul 2026 – 30 Oct 2026 | |
235LIFLIFE360 | 47.37+1.07% | Buy 10 · Hold 3 · Sell 0 · 77% Buy | 59.3432.20–76.00 | +25.3%+11.97 USD | 30 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 06:08 ET | 1616 firms | avg 7 Jul27 Jan 2026 – 30 Oct 2026 |
| 13.43+1.67% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 18.1013.00–23.00 | +34.8%+4.67 USD | 5 OctPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 03:26 ET | 1413 firms | avg 16 Jul5 Jan 2026 – 5 Oct 2026 | |
| 13.40+3.16% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 20.5014.00–25.00 | +53.0%+7.10 USD | 26 OctPartial coverage · checked 6 Nov | 3 DecEstimated | Partial coverage6 Nov 06:17 ET | 1211 firms | avg 1 Jul9 Dec 2025 – 26 Oct 2026 | |
| 10.86−3.29% | Buy 10 · Hold 2 · Sell 0 · 83% Buy | 18.1115.00–24.00 | +66.8%+7.25 USD | 22 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 03:28 ET | 1212 firms | avg 8 Jul8 Jun 2026 – 22 Sep 2026 | |
| 8.84−1.45% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 12.8911.00–16.00 | +45.8%+4.05 USD | 21 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 06:58 ET | 1211 firms | avg 27 Jun14 Nov 2025 – 21 Oct 2026 | |
| 25.31−1.33% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 79.8960.00–166.00 | +215.6%+54.58 USD | 28 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 07:00 ET | 1313 firms | avg 10 Jul27 Feb 2026 – 28 Oct 2026 | |
| 5.34+18.03% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 17.9810.00–25.00 | +237.0%+12.64 USD | 5 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 04:43 ET | 1515 firms | avg 23 Jun26 Nov 2025 – 5 Oct 2026 | |
242PCVXVAXCYTE | 63.89+3.18% | Buy 10 · Hold 2 · Sell 0 · 83% Buy | 115.0075.00–163.00 | +80.0%+51.11 USD | 13 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:06 ET | 1212 firms | avg 24 Jul19 Feb 2026 – 13 Oct 2026 |
| 11.75+19.29% | Buy 10 · Hold 5 · Sell 0 · 67% Buy | 27.3315.00–40.00 | +132.6%+15.58 USD | 6 OctPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 04:10 ET | 1615 firms | avg 25 Jun5 Mar 2026 – 6 Oct 2026 | |
244SIBNSI BONE | 24.24−0.12% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 25.6020.00–32.00 | +5.6%+1.36 USD | 14 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:05 ET | 1211 firms | avg 27 Jun2 Dec 2025 – 14 Oct 2026 |
245SVRASAVARA | 4.83+10.27% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 10.799.00–16.00 | +123.4%+5.96 USD | 7 OctPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 06:09 ET | 1515 firms | avg 4 Jun23 Dec 2025 – 7 Oct 2026 |
| 2.30+7.98% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 26.5724.00–30.00 | +1,055.3%+24.27 USD | 12 AugPartial coverage · checked 6 Nov | 10 NovEstimated | Partial coverage6 Nov 03:25 ET | 1211 firms | avg 12 May23 Feb 2026 – 12 Aug 2026 | |
| 3.55+2.01% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 25.0013.00–40.00 | +604.2%+21.45 USD | 29 SepPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 03:41 ET | 1212 firms | avg 19 Jul30 Mar 2026 – 29 Sep 2026 | |
| 1.87+8.43% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 15.008.00–25.00 | +704.3%+13.14 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 08:12 ET | 1212 firms | avg 3 Jun11 Mar 2026 – 28 Oct 2026 | |
| 4.09+9.95% | Buy 10 · Hold 1 · Sell 0 · 91% Buy | 16.4311.00–22.00 | +301.7%+12.34 USD | 27 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:54 ET | 1212 firms | avg 1 Jun13 Nov 2025 – 27 Oct 2026 | |
| 124.31−1.97% | Buy 10 · Hold 4 · Sell 1 · 67% Buy | 135.09115.00–150.00 | +8.7%+10.78 USD | 28 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:53 ET | 1716 firms | avg 21 Jun24 Feb 2026 – 28 Sep 2026 | |
- ZVRA#201ZEVRA THERAPEUTICS INC11.59+10.07%
Buy 11 · Hold 1 · Sell 0 · 92% Buy
Target 25.29 (20.00–35.00)+118.2%
Details
- Latest target report
- 21 Sep 2026
- Report dates
- 10 Jun 2026 – 21 Sep 2026 · avg 31 Jul 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BHVN#202BIOHAVEN14.48+4.17%
Buy 11 · Hold 5 · Sell 1 · 65% Buy
Target 21.40 (10.00–48.00)+47.8%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 18 Nov 2025 – 3 Nov 2026 · avg 20 Jul 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CWH#203CAMPING WORLD HOLDINGS INC CLASS A4.59−10.00%
Buy 11 · Hold 1 · Sell 1 · 85% Buy
Target 10.44 (5.30–16.00)+127.5%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 26 Feb 2026 – 19 Oct 2026 · avg 10 Aug 2026
- Analysts
- 16 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- FLG#204FLAGSTAR BANK NATIONAL ASSOCIATION10.52−0.75%
Buy 11 · Hold 4 · Sell 1 · 69% Buy
Target 13.52 (8.75–17.50)+28.5%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 28 Sep 2026 – 30 Oct 2026 · avg 21 Oct 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- 29 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- INR#205INFINITY NATURAL RESOURCES INC CLA12.79+4.41%
Buy 11 · Hold 0 · Sell 1 · 92% Buy
Target 21.86 (17.00–26.00)+70.9%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 25 Jun 2026 – 21 Oct 2026 · avg 8 Sep 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- MBX#206MBX BIOSCIENCES51.35+5.96%
Buy 11 · Hold 1 · Sell 1 · 85% Buy
Target 87.00 (19.00–150.00)+69.4%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 13 Mar 2026 – 13 Oct 2026 · avg 14 Jul 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- PENG#207PENGUIN SOLUTIONS INC41.83+12.39%
Buy 11 · Hold 0 · Sell 1 · 92% Buy
Target 87.00 (60.00–100.00)+108.0%
Details
- Latest target report
- 9 Oct 2026
- Report dates
- 15 Apr 2026 – 9 Oct 2026 · avg 2 Sep 2026
- Analysts
- 14 analysts · 12 firms
- Next earnings
- 5 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- VGNT#208VERSIGENT PLC40.96+1.69%
Buy 11 · Hold 1 · Sell 1 · 85% Buy
Target 55.25 (50.00–65.00)+34.9%
Details
- Latest target report
- 5 Nov 2026
- Report dates
- 8 May 2026 – 5 Nov 2026 · avg 21 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ACRS#209ACLARIS THERAPEUTICS3.90+8.03%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 10.45 (7.00–16.00)+168.1%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 6 Jan 2026 – 28 Oct 2026 · avg 15 Jul 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- AKTS#210AKTIS ONCOLOGY INC15.82+6.53%
Buy 10 · Hold 0 · Sell 0 · 100% Buy
Target 35.88 (33.00–40.00)+126.8%
Details
- Latest target report
- 2 Oct 2026
- Report dates
- 3 Feb 2026 – 2 Oct 2026 · avg 7 Jul 2026
- Analysts
- 11 analysts · 11 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- ALHC#211ALIGNMENT HEALTHCARE7.34−2.91%
Buy 10 · Hold 5 · Sell 0 · 67% Buy
Target 15.23 (8.00–28.00)+107.5%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 6 Jul 2026 – 30 Oct 2026 · avg 20 Sep 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ALT#212ALTIMMUNE INC2.08+5.58%
Buy 10 · Hold 3 · Sell 0 · 77% Buy
Target 13.95 (2.50–28.00)+570.7%
Details
- Latest target report
- 23 Sep 2026
- Report dates
- 27 Jan 2026 – 23 Sep 2026 · avg 8 Jun 2026
- Analysts
- 14 analysts · 13 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- AMPL#213AMPLITUDE CLASS A16.70+3.73%
Buy 10 · Hold 4 · Sell 0 · 71% Buy
Target 14.59 (10.00–18.00)−12.6%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 1 Jun 2026 – 20 Oct 2026 · avg 15 Aug 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ANRO#214ALTO NEUROSCIENCE INC25.16+15.04%
Buy 10 · Hold 2 · Sell 0 · 83% Buy
Target 38.11 (26.00–60.00)+51.5%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 2 Apr 2026 – 19 Oct 2026 · avg 8 Jul 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- AVEX#215AEVEX CORP CLASS A10.20+10.15%
Buy 10 · Hold 2 · Sell 0 · 83% Buy
Target 28.45 (13.00–45.00)+179.0%
Details
- Latest target report
- 22 Oct 2026
- Report dates
- 12 May 2026 – 22 Oct 2026 · avg 24 Aug 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- 11 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- BETA#216BETA TECHNOLOGIES CLASS A27.12+12.77%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 31.40 (24.00–37.00)+15.8%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 17 Dec 2025 – 21 Oct 2026 · avg 21 Jun 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BNTC#217BENITEC BIOPHARMA INC9.54+10.42%
Buy 10 · Hold 2 · Sell 0 · 83% Buy
Target 22.86 (14.00–32.00)+139.6%
Details
- Latest target report
- 23 Oct 2026
- Report dates
- 25 Feb 2026 – 23 Oct 2026 · avg 12 Jul 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- CCCC#218C4 THERAPEUTICS3.10+5.08%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 14.56 (7.00–30.00)+369.5%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 23 Feb 2026 – 28 Oct 2026 · avg 21 Jul 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CNK#219CINEMARK HOLDINGS INC38.90−2.85%
Buy 10 · Hold 6 · Sell 0 · 63% Buy
Target 39.60 (30.00–48.00)+1.8%
Details
- Latest target report
- 23 Oct 2026
- Report dates
- 2 Jul 2026 – 23 Oct 2026 · avg 23 Aug 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- COCO#220THE VITA COCO COMPANY62.45−1.85%
Buy 10 · Hold 4 · Sell 0 · 71% Buy
Target 75.55 (54.00–90.00)+21.0%
Details
- Latest target report
- 23 Oct 2026
- Report dates
- 17 Nov 2025 – 23 Oct 2026 · avg 21 Jul 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CON#221CONCENTRA GROUP HOLDINGS PARENT IN42.22+0.17%
Buy 10 · Hold 0 · Sell 0 · 100% Buy
Target 42.71 (40.00–47.00)+1.2%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 10 May 2026 – 20 Oct 2026 · avg 21 Aug 2026
- Analysts
- 11 analysts · 11 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CRBP#222CORBUS PHARMACEUTICALS HOLDINGS3.07+7.34%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 35.60 (28.00–48.00)+1,059.6%
Details
- Latest target report
- 14 Sep 2026
- Report dates
- 9 Mar 2026 – 14 Sep 2026 · avg 9 Jul 2026
- Analysts
- 13 analysts · 12 firms
- Next earnings
- 16 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- DEC#223DIVERSIFIED ENERGY COMPANY12.70−0.78%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 21.67 (15.00–29.00)+70.6%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 25 Nov 2025 – 16 Oct 2026 · avg 7 Jul 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- DMRA#224DAMORA THERAPEUTICS INC23.70+8.42%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 46.89 (40.00–60.00)+97.8%
Details
- Latest target report
- 29 Sep 2026
- Report dates
- 17 Feb 2026 – 29 Sep 2026 · avg 22 Jun 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- DRUG#225BRIGHT MINDS BIOSCIENCES23.00+11.11%
Buy 10 · Hold 2 · Sell 0 · 83% Buy
Target 146.33 (107.00–220.00)+536.2%
Details
- Latest target report
- 3 Nov 2026
- Report dates
- 19 Aug 2026 – 3 Nov 2026 · avg 4 Oct 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- EDIT#226EDITAS MEDICINE2.57+0.78%
Buy 10 · Hold 3 · Sell 0 · 77% Buy
Target 6.14 (3.50–15.00)+138.8%
Details
- Latest target report
- 8 Oct 2026
- Report dates
- 10 Mar 2026 – 8 Oct 2026 · avg 26 Jun 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- GLUE#227MONTE ROSA THERAPEUTICS10.57+3.12%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 27.63 (25.00–37.00)+161.4%
Details
- Latest target report
- 5 Oct 2026
- Report dates
- 27 Jul 2026 – 5 Oct 2026 · avg 26 Aug 2026
- Analysts
- 14 analysts · 14 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- HTFL#228HEARTFLOW INC52.40+0.87%
Buy 10 · Hold 3 · Sell 0 · 77% Buy
Target 48.11 (39.00–64.00)−8.2%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 30 Jun 2026 – 20 Oct 2026 · avg 24 Aug 2026
- Analysts
- 15 analysts · 14 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- IMVT#229IMMUNOVANT30.53+7.54%
Buy 10 · Hold 6 · Sell 0 · 63% Buy
Target 45.46 (30.00–62.00)+48.9%
Details
- Latest target report
- 24 Sep 2026
- Report dates
- 2 Apr 2026 – 24 Sep 2026 · avg 8 Jul 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- INSW#230INTERNATIONAL SEAWAYS98.02+3.76%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 106.67 (56.00–140.00)+8.8%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 21 Jan 2026 – 16 Oct 2026 · avg 19 Jul 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- KEEL#231KEEL INFRASTRUCTURE CORP1.87+13.33%
Buy 10 · Hold 2 · Sell 0 · 83% Buy
Target 6.15 (4.00–10.00)+228.9%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 11 May 2026 – 29 Oct 2026 · avg 4 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- LBRT#232LIBERTY ENERGY CLASS A11.96+5.37%
Buy 10 · Hold 5 · Sell 0 · 67% Buy
Target 26.92 (19.00–36.00)+125.1%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 10 Dec 2025 – 26 Oct 2026 · avg 9 Aug 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- 27 Jan · Estimated
- Research
- Partial coverage · checked 6 Nov
- LFMD#233LIFEMD INC2.37+3.49%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 7.80 (5.00–15.00)+229.1%
Details
- Latest target report
- 17 Sep 2026
- Report dates
- 7 May 2026 – 17 Sep 2026 · avg 9 Aug 2026
- Analysts
- 13 analysts · 11 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- LGND#234LIGAND PHARMACEUTICALS306.20+2.41%
Buy 10 · Hold 0 · Sell 0 · 100% Buy
Target 353.80 (326.00–397.00)+15.5%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 8 Jul 2026 – 30 Oct 2026 · avg 22 Aug 2026
- Analysts
- 11 analysts · 11 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- LIF#235LIFE36047.37+1.07%
Buy 10 · Hold 3 · Sell 0 · 77% Buy
Target 59.34 (32.20–76.00)+25.3%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 27 Jan 2026 – 30 Oct 2026 · avg 7 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- LMRI#236LUMEXA IMAGING HOLDINGS13.43+1.67%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 18.10 (13.00–23.00)+34.8%
Details
- Latest target report
- 5 Oct 2026
- Report dates
- 5 Jan 2026 – 5 Oct 2026 · avg 16 Jul 2026
- Analysts
- 14 analysts · 13 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- MAMA#237MAMAS CREATIONS INC13.40+3.16%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 20.50 (14.00–25.00)+53.0%
Details
- Latest target report
- 26 Oct 2026
- Report dates
- 9 Dec 2025 – 26 Oct 2026 · avg 1 Jul 2026
- Analysts
- 12 analysts · 11 firms
- Next earnings
- 3 Dec · Estimated
- Research
- Partial coverage · checked 6 Nov
- MH#238MCGRAW HILL10.86−3.29%
Buy 10 · Hold 2 · Sell 0 · 83% Buy
Target 18.11 (15.00–24.00)+66.8%
Details
- Latest target report
- 22 Sep 2026
- Report dates
- 8 Jun 2026 – 22 Sep 2026 · avg 8 Jul 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- NEXN#239NEXXEN INTERNATIONAL LTD8.84−1.45%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 12.89 (11.00–16.00)+45.8%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 14 Nov 2025 – 21 Oct 2026 · avg 27 Jun 2026
- Analysts
- 12 analysts · 11 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- NGNE#240NEUROGENE25.31−1.33%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 79.89 (60.00–166.00)+215.6%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 27 Feb 2026 – 28 Oct 2026 · avg 10 Jul 2026
- Analysts
- 13 analysts · 13 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- ONDS#241ONDAS INC5.34+18.03%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 17.98 (10.00–25.00)+237.0%
Details
- Latest target report
- 5 Oct 2026
- Report dates
- 26 Nov 2025 – 5 Oct 2026 · avg 23 Jun 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- PCVX#242VAXCYTE63.89+3.18%
Buy 10 · Hold 2 · Sell 0 · 83% Buy
Target 115.00 (75.00–163.00)+80.0%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 19 Feb 2026 – 13 Oct 2026 · avg 24 Jul 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RGTI#243RIGETTI COMPUTING11.75+19.29%
Buy 10 · Hold 5 · Sell 0 · 67% Buy
Target 27.33 (15.00–40.00)+132.6%
Details
- Latest target report
- 6 Oct 2026
- Report dates
- 5 Mar 2026 – 6 Oct 2026 · avg 25 Jun 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- SIBN#244SI BONE24.24−0.12%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 25.60 (20.00–32.00)+5.6%
Details
- Latest target report
- 14 Oct 2026
- Report dates
- 2 Dec 2025 – 14 Oct 2026 · avg 27 Jun 2026
- Analysts
- 12 analysts · 11 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SVRA#245SAVARA4.83+10.27%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 10.79 (9.00–16.00)+123.4%
Details
- Latest target report
- 7 Oct 2026
- Report dates
- 23 Dec 2025 – 7 Oct 2026 · avg 4 Jun 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- TARA#246PROTARA THERAPEUTICS INC2.30+7.98%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 26.57 (24.00–30.00)+1,055.3%
Details
- Latest target report
- 12 Aug 2026
- Report dates
- 23 Feb 2026 – 12 Aug 2026 · avg 12 May 2026
- Analysts
- 12 analysts · 11 firms
- Next earnings
- 10 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- UNCY#247UNICYCIVE THERAPEUTICS INC3.55+2.01%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 25.00 (13.00–40.00)+604.2%
Details
- Latest target report
- 29 Sep 2026
- Report dates
- 30 Mar 2026 – 29 Sep 2026 · avg 19 Jul 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- VYGR#248VOYAGER THERAPEUTICS1.87+8.43%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 15.00 (8.00–25.00)+704.3%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 11 Mar 2026 – 28 Oct 2026 · avg 3 Jun 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ZURA#249ZURA BIO LTD CLASS A4.09+9.95%
Buy 10 · Hold 1 · Sell 0 · 91% Buy
Target 16.43 (11.00–22.00)+301.7%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 13 Nov 2025 – 27 Oct 2026 · avg 1 Jun 2026
- Analysts
- 12 analysts · 12 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ADUS#250ADDUS HOMECARE CORP124.31−1.97%
Buy 10 · Hold 4 · Sell 1 · 67% Buy
Target 135.09 (115.00–150.00)+8.7%
Details
- Latest target report
- 28 Sep 2026
- Report dates
- 24 Feb 2026 – 28 Sep 2026 · avg 21 Jun 2026
- Analysts
- 17 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
Showing 201–250 of 1,952Load more
About the Russell 2000 analyst ratings
US small-cap stocks in the Russell 2000. Smaller companies usually have fewer analysts.. For each stock Analyst Radar counts the latest Buy, Hold or Sell rating of every analyst who covers it within the chosen window (one vote per analyst) and averages their price targets in US dollars. Upside is the average target against the current price; the range is the lowest and highest target. The stocks our model scores highest are collected in Radar picks. Research is refreshed daily and prices stream live during the US session.
A summary of analyst opinion, not investment advice.